NASDAQ:VIVE Viveve Medical (VIVE) Stock Price, News & Analysis → Reclusive millionaire’s final warning about America (From Weiss Ratings) (Ad) Free VIVE Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume3,344 shsMarket Capitalization$3,000.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsSEC FilingsTrendsStock AnalysisChartCompetitorsFinancialsSEC FilingsTrends Get Viveve Medical alerts: Email Address Ad Behind the MarketsThe Military's $700M "AI Software Bullet"The Pentagon is spending over $700 MILLION on a top-secret project called "Overmatch." It's a software-defined networking solution that will connect all sensors, weapons, platforms, and personnel across our military branches.Get the name and stock ticker of this critical military tech firm HERE>>> About Viveve Medical Stock (NASDAQ:VIVE)Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.Read More Ad Behind the MarketsThe Military's $700M "AI Software Bullet"The Pentagon is spending over $700 MILLION on a top-secret project called "Overmatch." It's a software-defined networking solution that will connect all sensors, weapons, platforms, and personnel across our military branches.Get the name and stock ticker of this critical military tech firm HERE>>> VIVE Stock News HeadlinesApril 17, 2024 | finance.yahoo.com5-Alpha Reductase Deficiency Global Market Report 2024: A $1.94 Billion Projected Market in 2028April 15, 2024 | finance.yahoo.comInMode Responds To BTL Petition for Inter Partes Review Of Patent InMode Is Asserting Against BTLFebruary 23, 2024 | benzinga.comViveve Medical Stock (OTC:VIVE), Analyst Ratings, Price Targets, PredictionsJuly 29, 2023 | seekingalpha.comVIVE Viveve Medical, Inc.July 25, 2023 | finance.yahoo.comInMode Expands Women's Health and Wellness Market Footprint through Acquisition of Viveve PatentsJune 14, 2023 | uk.finance.yahoo.comVIVE - Viveve Medical, Inc.February 24, 2023 | finance.yahoo.comViveve Medical, Inc. (VIVE)January 17, 2023 | msn.comWhy Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionJanuary 17, 2023 | finanznachrichten.deViveve Medical, Inc.: Viveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary IncontinenceJanuary 17, 2023 | seekingalpha.comViveve crashes ~60% as company decides to delist, explore sale after trial failsJanuary 17, 2023 | finance.yahoo.comViveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary IncontinenceJanuary 17, 2023 | finance.yahoo.comViveve Medical Seeks Strategic Alternatives After Failed Stress Urinary Incontinence TrialJanuary 17, 2023 | investorplace.comWhy Is Viveve Medical (VIVE) Stock Down 69% Today?December 29, 2022 | insidermonkey.comViveve Medical, Inc. (NASDAQ:VIVE) Q3 2022 Earnings Call TranscriptDecember 15, 2022 | finance.yahoo.comViveve Announces Completion of Pivotal US PURSUIT Trial for Female Stress Urinary Incontinence with Final 12-month Follow-up Visits ConcludedDecember 1, 2022 | finanznachrichten.deViveve Medical, Inc.: Viveve Announces Issuance of Second U.S. Method Patent for Treating Female Stress Urinary IncontinenceDecember 1, 2022 | finance.yahoo.comViveve Announces Issuance of Second U.S. Method Patent for Treating Female Stress Urinary IncontinenceNovember 13, 2022 | finance.yahoo.comViveve Medical Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues LagNovember 10, 2022 | finanznachrichten.deViveve Medical, Inc.: Viveve Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateNovember 10, 2022 | finance.yahoo.comViveve Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateOctober 27, 2022 | finance.yahoo.comViveve to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 10, 2022October 25, 2022 | finance.yahoo.comGlobal Cosmetic Gynecology Market Report to 2027 - Featuring Alma Laser, Lutronic, Viveve Medical and Venus Concept Among OthersOctober 13, 2022 | forbes.comViveve MedicalOctober 4, 2022 | finanznachrichten.deViveve Medical, Inc.: Viveve Announces Notice of Allowance for Second U.S. Method Patent for Treating Female Stress Urinary IncontinenceOctober 4, 2022 | finance.yahoo.comViveve Announces Notice of Allowance for Second U.S. Method Patent for Treating Female Stress Urinary IncontinenceSee More Headlines Receive VIVE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Viveve Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/11/2021Today6/17/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryN/A Current SymbolNASDAQ:VIVE Previous SymbolOTCMKTS:PLCSD CUSIPN/A CIK879682 Webwww.viveve.com Phone(720) 696-8100Fax720-696-8199Employees47Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$6.43 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares10,720,000Free Float10,110,000Market Cap$3,000.00 OptionableNot Optionable Beta0.44 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. Jim B. Robbins (Age 60)Senior VP of Finance & Administration and Principal Accounting & Financial Officer Comp: $386.94kMs. Deborah Ann Jorn M.B.A. (Age 66)Senior Advisor to the CEO & Director Comp: $35kMr. Martin Kerber P.E.Vice President of Research, Development & OperationsMs. Jeannie SwindleSenior Director of Corporate CommunicationsMr. Jeff SinclairVice President of International SalesMr. Gary KaiserVice President of Global MarketingMs. Lori McMillanVice President of Human ResourcesMs. Suzon D. Lommel (Age 66)Senior Vice President of Regulatory & Quality Affairs More ExecutivesKey CompetitorsHologicNASDAQ:HOLXMedtronicNYSE:MDTMasimoNASDAQ:MASITransMedics GroupNASDAQ:TMDXIntegerNYSE:ITGRView All Competitors VIVE Stock Analysis - Frequently Asked Questions How were Viveve Medical's earnings last quarter? Viveve Medical, Inc. (NASDAQ:VIVE) posted its quarterly earnings data on Thursday, November, 11th. The company reported ($0.67) earnings per share for the quarter, missing analysts' consensus estimates of ($0.58) by $0.09. The company had revenue of $1.62 million for the quarter. During the same quarter in the previous year, the company posted ($2.60) earnings per share. What other stocks do shareholders of Viveve Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Viveve Medical investors own include Corbus Pharmaceuticals (CRBP), Visa (V), HP (HPQ), Fortive (FTV), Lowe's Companies (LOW), SCYNEXIS (SCYX), Western Digital (WDC), Inovio Pharmaceuticals (INO), Viking Therapeutics (VKTX) and Novavax (NVAX). When did Viveve Medical IPO? Viveve Medical (VIVE) raised $13 million in an initial public offering (IPO) on Tuesday, June 14th 2016. The company issued 1,600,000 shares at a price of $8.00 per share. Ladenburg Thalmann and Craig-Hallum Capital Group acted as the underwriters for the IPO and Maxim Group was co-manager. How do I buy shares of Viveve Medical? Shares of VIVE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:VIVE) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredRadical change coming — do this NOW to protect yourselfI recently uncovered a way the government could use the next crisis as a pretext to gain more control … and ra...Weiss Ratings | SponsoredUnexpected twist to Trump’s trialUnexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...Stansberry Research | SponsoredElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | SponsoredMissed NVDA? Buy this AI stock NOWAfter Nvidia's record-breaking earnings surge, Wall Street is now selling the stock at the fastest pace in sev...Chaikin Analytics | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | SponsoredHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viveve Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viveve Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.